Found 2 hits Enz. Inhib. hit(s) with Target = 'IgG receptor FcRn large subunit p51' and Ligand = 'BDBM50270966' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
IgG receptor FcRn large subunit p51
(Homo sapiens (Human)) | BDBM50270966
((2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-{2-[(3R)-3-[(2S)-2...)Show SMILES CC(C)C[C@H](N(C)C(=O)CN1CCCC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(O)=O |r,wU:103.108,84.87,15.15,63.66,19.27,99.105,wD:4.4,44.46,76.80,30.38,52.62,48.50,(28.01,-21.12,;28.01,-19.59,;29.34,-18.82,;26.69,-18.82,;26.69,-17.29,;25.49,-16.41,;25.47,-14.87,;24.26,-17.34,;24.19,-18.87,;22.84,-16.75,;21.62,-17.68,;21.93,-19.19,;20.95,-20.37,;19.4,-20.34,;18.46,-19.12,;18.84,-17.62,;17.65,-16.64,;16.3,-17.37,;16.31,-18.92,;15.02,-16.5,;15.02,-14.95,;16.35,-14.18,;17.67,-14.96,;19,-14.19,;19.01,-12.65,;17.67,-11.88,;16.34,-12.65,;13.8,-17.39,;12.44,-16.67,;12.45,-15.12,;11.17,-17.53,;11.17,-19.08,;12.5,-19.85,;13.96,-19.36,;14.88,-20.59,;13.99,-21.84,;12.52,-21.38,;9.78,-16.64,;8.42,-17.37,;8.43,-18.91,;7.15,-16.5,;5.94,-17.39,;4.58,-16.67,;4.59,-15.12,;3.3,-17.53,;2.09,-16.64,;.76,-17.42,;.77,-18.97,;-.58,-16.66,;-1.91,-17.44,;-3.27,-16.72,;-3.26,-15.17,;-4.55,-17.58,;-4.55,-19.14,;-3.22,-19.92,;-1.88,-19.14,;-.54,-19.92,;-.54,-21.47,;-1.88,-22.23,;-3.22,-21.47,;-5.77,-16.7,;-7.13,-17.42,;-7.12,-18.97,;-8.41,-16.55,;-9.63,-17.44,;-8.41,-14.99,;-7.07,-14.23,;-7.07,-12.68,;-5.74,-11.96,;-5.7,-10.41,;-4.35,-9.68,;-7.02,-9.61,;-.59,-15.11,;-2.14,-15.13,;-.6,-13.56,;.96,-15.11,;3.3,-19.08,;1.97,-19.85,;4.64,-19.84,;20.24,-16.98,;20.27,-15.44,;27.96,-16.43,;27.96,-14.9,;29.31,-17.16,;30.52,-16.27,;30.52,-14.73,;31.59,-13.64,;33.08,-14.02,;34.16,-12.93,;33.74,-11.45,;34.82,-10.35,;32.25,-11.07,;31.18,-12.16,;31.78,-17.13,;31.79,-18.67,;33.14,-16.41,;33.35,-14.9,;34.87,-14.63,;35.59,-15.99,;34.52,-17.09,;34.78,-18.61,;33.61,-19.59,;36.23,-19.14,;37.44,-18.27,;37.45,-16.72,;38.77,-15.96,;38.71,-19.12,;40.07,-18.39,;38.72,-20.65,)| Show InChI InChI=1S/C73H104N18O16S2/c1-41(2)31-56(66(101)85-53(34-45-24-26-47(93)27-25-45)70(105)91-30-16-23-55(91)65(100)86-54(39-108)71(106)107)89(6)58(95)38-90-29-14-13-22-49(69(90)104)82-62(97)50(32-43-17-9-7-10-18-43)84-63(98)52(35-46-36-77-40-80-46)81-57(94)37-79-67(102)59(42(3)92)87-68(103)60(73(4,5)109)88-64(99)51(33-44-19-11-8-12-20-44)83-61(96)48(74)21-15-28-78-72(75)76/h7-12,17-20,24-27,36,40-42,48-56,59-60,92-93,108-109H,13-16,21-23,28-35,37-39,74H2,1-6H3,(H,77,80)(H,79,102)(H,81,94)(H,82,97)(H,83,96)(H,84,98)(H,85,101)(H,86,100)(H,87,103)(H,88,99)(H,106,107)(H4,75,76,78)/t42-,48+,49-,50+,51+,52+,53+,54+,55+,56+,59+,60+/m1/s1 | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 620 | n/a | n/a | n/a | n/a | n/a | n/a |
Syntonix Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human IgG binding to soluble human FcRn by ELISA |
Bioorg Med Chem 16: 6394-405 (2008)
Article DOI: 10.1016/j.bmc.2008.05.004
BindingDB Entry DOI: 10.7270/Q2QV3M9C |
More data for this
Ligand-Target Pair | |
IgG receptor FcRn large subunit p51
(Homo sapiens (Human)) | BDBM50270966
((2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-{2-[(3R)-3-[(2S)-2...)Show SMILES CC(C)C[C@H](N(C)C(=O)CN1CCCC[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CCCN=C(N)N)C(C)(C)S)[C@@H](C)O)C1=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(O)=O |r,wU:103.108,84.87,15.15,63.66,19.27,99.105,wD:4.4,44.46,76.80,30.38,52.62,48.50,(28.01,-21.12,;28.01,-19.59,;29.34,-18.82,;26.69,-18.82,;26.69,-17.29,;25.49,-16.41,;25.47,-14.87,;24.26,-17.34,;24.19,-18.87,;22.84,-16.75,;21.62,-17.68,;21.93,-19.19,;20.95,-20.37,;19.4,-20.34,;18.46,-19.12,;18.84,-17.62,;17.65,-16.64,;16.3,-17.37,;16.31,-18.92,;15.02,-16.5,;15.02,-14.95,;16.35,-14.18,;17.67,-14.96,;19,-14.19,;19.01,-12.65,;17.67,-11.88,;16.34,-12.65,;13.8,-17.39,;12.44,-16.67,;12.45,-15.12,;11.17,-17.53,;11.17,-19.08,;12.5,-19.85,;13.96,-19.36,;14.88,-20.59,;13.99,-21.84,;12.52,-21.38,;9.78,-16.64,;8.42,-17.37,;8.43,-18.91,;7.15,-16.5,;5.94,-17.39,;4.58,-16.67,;4.59,-15.12,;3.3,-17.53,;2.09,-16.64,;.76,-17.42,;.77,-18.97,;-.58,-16.66,;-1.91,-17.44,;-3.27,-16.72,;-3.26,-15.17,;-4.55,-17.58,;-4.55,-19.14,;-3.22,-19.92,;-1.88,-19.14,;-.54,-19.92,;-.54,-21.47,;-1.88,-22.23,;-3.22,-21.47,;-5.77,-16.7,;-7.13,-17.42,;-7.12,-18.97,;-8.41,-16.55,;-9.63,-17.44,;-8.41,-14.99,;-7.07,-14.23,;-7.07,-12.68,;-5.74,-11.96,;-5.7,-10.41,;-4.35,-9.68,;-7.02,-9.61,;-.59,-15.11,;-2.14,-15.13,;-.6,-13.56,;.96,-15.11,;3.3,-19.08,;1.97,-19.85,;4.64,-19.84,;20.24,-16.98,;20.27,-15.44,;27.96,-16.43,;27.96,-14.9,;29.31,-17.16,;30.52,-16.27,;30.52,-14.73,;31.59,-13.64,;33.08,-14.02,;34.16,-12.93,;33.74,-11.45,;34.82,-10.35,;32.25,-11.07,;31.18,-12.16,;31.78,-17.13,;31.79,-18.67,;33.14,-16.41,;33.35,-14.9,;34.87,-14.63,;35.59,-15.99,;34.52,-17.09,;34.78,-18.61,;33.61,-19.59,;36.23,-19.14,;37.44,-18.27,;37.45,-16.72,;38.77,-15.96,;38.71,-19.12,;40.07,-18.39,;38.72,-20.65,)| Show InChI InChI=1S/C73H104N18O16S2/c1-41(2)31-56(66(101)85-53(34-45-24-26-47(93)27-25-45)70(105)91-30-16-23-55(91)65(100)86-54(39-108)71(106)107)89(6)58(95)38-90-29-14-13-22-49(69(90)104)82-62(97)50(32-43-17-9-7-10-18-43)84-63(98)52(35-46-36-77-40-80-46)81-57(94)37-79-67(102)59(42(3)92)87-68(103)60(73(4,5)109)88-64(99)51(33-44-19-11-8-12-20-44)83-61(96)48(74)21-15-28-78-72(75)76/h7-12,17-20,24-27,36,40-42,48-56,59-60,92-93,108-109H,13-16,21-23,28-35,37-39,74H2,1-6H3,(H,77,80)(H,79,102)(H,81,94)(H,82,97)(H,83,96)(H,84,98)(H,85,101)(H,86,100)(H,87,103)(H,88,99)(H,106,107)(H4,75,76,78)/t42-,48+,49-,50+,51+,52+,53+,54+,55+,56+,59+,60+/m1/s1 | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | 44 | n/a | n/a | n/a | 6.0 | n/a |
Syntonix Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description
Binding affinity to human FcRn at pH 6 by surface plasmon resonance assay |
Bioorg Med Chem 16: 6394-405 (2008)
Article DOI: 10.1016/j.bmc.2008.05.004
BindingDB Entry DOI: 10.7270/Q2QV3M9C |
More data for this
Ligand-Target Pair | |
Search and Browse
